Active Impact Investments
Active Impact Investments
Type of Funding
Venture Capital
Max Funding
2,000,000.00
Region
Federal/National
Application Difficuty
Fairly simple
Processing Time
Slow (A few months)
Province
All Of Canada
Industry
Other.
Funding Goals
Start-up Funding.
Demographic
N/A
Incorporated
No
Contact
info@activeimpactinvestments.com
778-866-1447
Apply For A Loan
Business location – Canada
Monthly Revenue – $10K +
Time in Business – 6 months +
Funds in 24 hours
$10,000 to $800,000
Details
They are a private equity fund investing in early stage businesses.
Their team consists of an internal leadership team, an advisory team that assists our leadership team with fund operations and a post investment support team comprised of management, advisors and investors in our fund that offer their expertise and connections to our portfolio companies.
Eligibility
Early Stage Businesses
Similar funding programs
Venture Capital
7 Gate Ventures is a venture capital firm based in Vancouver, Canada and Silicon Valley, investing in early-stage startups from Seed to pre-Series A in the Technology industry, with a sector focus on Software, SaaS, Cloud Services, Marketplaces, Mobile Apps and Solutions, Big Data/Analytics, Blockchain, Fintec, and HealthTech.
Max Funding N/A
7 Gate Ventures
Venture Capital
Build Ventures is based in Halifax, Nova Scotia and is focused on early stage technology companies across the Atlantic region.
Their first fund closed in early 2013 and we currently have $65M under management.
They are looking to work with passionate founders who are committed to building great companies.
Max Funding N/A
Build Ventures
Venture Capital
Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology.
Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising biotechnology investment opportunities.
Genesys is one of the largest Canadian-based venture capital firms exclusively focused on the life sciences industry.
Max Funding N/A
Genesys Capital